Health Condition 1: null- Chronic Periodontitis Patients
Conditions
Interventions
Intervention1: 1.2% Atorvastatin gel: This is a interventional trial to evaluate the efficacy of 1.2% Atorvastatin gel as an adjunct to nonsurgical periodontal therapy in treatment of intrabony defect
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: Patients with moderate to severe chronic periodontitis as assessed by probing pocket depth (PPD) greater than or equal to 5mm and clinical attachment level (CAL) greater than or equal to 5mm Patients with at least one pair of bilateral intrabony defects in either maxillary or mandibular arch
Exclusion criteria
Exclusion criteria: Patients on systemic Atorvastatin or statin therapy Pregnant or lactating women Patient who has undergone periodontal treatment in previous 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Periodontal Status that is reduction in Probing Pocket Depth gain in Clinical Attachment Level Bone Fill in intrabony defects seen by advanced radiography that is RVG at baseline 3 and 6 months CBCT at baseline and 6 monthsTimepoint: Baseline 3 months 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in Plaque scores and Gingival Bleeding scores representing improvement in Gingival status at 3 and 6 monthsTimepoint: 3 months 6 months | — |
Countries
India
Contacts
Public ContactDr Abhay Kolte
VSPM Dental College and Research Centre
Outcome results
None listed